138
Views
36
CrossRef citations to date
0
Altmetric
Review

Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines

, &
Pages 319-336 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Carmen Baccarini, Andrew Ternouth, Heather Wieffer & Andrew Vyse. (2013) The changing epidemiology of meningococcal disease in North America 1945–2010. Human Vaccines & Immunotherapeutics 9:1, pages 162-171.
Read now

Articles from other publishers (35)

T. Koutangni, P. Crépey, M. Woringer, S. Porgho, B. W. Bicaba, H. Tall & J. E. Mueller. (2018) Compartmental models for seasonal hyperendemic bacterial meningitis in the African meningitis belt. Epidemiology and Infection 147.
Crossref
Gunnstein Norheim, Judith E. Mueller, Berthe-Marie Njanpop-Lafourcade, Isabelle Delrieu, Helen Findlow, Ray Borrow, Ouli Xie, Jerry Nagaputra, Roshan Ramasamy, Christina Dold, Tsidi Agbeko Tamekloe, Christine S. Rollier, Hilary Watt, Abiba Banla Kere, Lisbeth M. Næss & Andrew J. Pollard. (2018) Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007. Vaccine 36:10, pages 1297-1303.
Crossref
Oumy Thiongane, Janice Graham & Hélène Broutin. (2017) Lueurs et leurres de la santé globale. Anthropologie & développement:46-47, pages 213-234.
Crossref
Fortress Y. Aku, Fernanda C. Lessa, Franklin Asiedu-Bekoe, Phoebe Balagumyetime, Winfred Ofosu, Jennifer Farrar, Mahamoudou Ouattara, Jeni T. Vuong, Kofi Issah, Joseph Opare, Sally-Ann Ohene, Charles Okot, Ernest Kenu, Donne K. Ameme, David Opare & Abass Abdul-Karim. (2017) Meningitis Outbreak Caused by Vaccine-Preventable Bacterial Pathogens — Northern Ghana, 2016. MMWR. Morbidity and Mortality Weekly Report 66:30, pages 806-810.
Crossref
Caroline L Trotter, Clément Lingani, Katya Fernandez, Laura V Cooper, André Bita, Carol Tevi-Benissan, Olivier Ronveaux, Marie-Pierre Préziosi & James M Stuart. (2017) Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data. The Lancet Infectious Diseases 17:8, pages 867-872.
Crossref
Lydiane Agier, Nadège Martiny, Oumy Thiongane, Judith E. Mueller, Juliette Paireau, Eleanor R. Watkins, Tom J. Irving, Thibaut Koutangni & Hélène Broutin. (2017) Towards understanding the epidemiology of Neisseria meningitidis in the African meningitis belt: a multi-disciplinary overview. International Journal of Infectious Diseases 54, pages 103-112.
Crossref
Mustapha M. Mustapha, Jane W. Marsh, Mary G. Krauland, Jorge O. Fernandez, Ana Paula S. de Lemos, Julie C. Dunning Hotopp, Xin Wang, Leonard W. Mayer, Jeffrey G. Lawrence, N. Luisa Hiller & Lee H. Harrison. (2016) Genomic Investigation Reveals Highly Conserved, Mosaic, Recombination Events Associated with Capsular Switching among Invasive Neisseria meningitidis Serogroup W Sequence Type (ST)-11 Strains . Genome Biology and Evolution 8:6, pages 2065-2075.
Crossref
Mustapha M. Mustapha, Jane W. Marsh & Lee H. Harrison. (2016) Global epidemiology of capsular group W meningococcal disease (1970–2015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex. Vaccine 34:13, pages 1515-1523.
Crossref
Rolando Pajon, Eduardo Lujan & Dan M. Granoff. (2016) A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine. Vaccine 34:5, pages 643-649.
Crossref
Halima Boubacar Maïnassara, Juliette Paireau, Issa Idi, Jean-Paul Moulia Pelat, Odile Ouwe Missi Oukem-Boyer, Arnaud Fontanet & Judith E. Mueller. (2015) Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger. Emerging Infectious Diseases 21:8, pages 1322-1329.
Crossref
Berthe-Marie Njanpop-Lafourcade, Stéphane Hugonnet, Honoré Djogbe, Agbenoko Kodjo, Adèle Kacou N’douba, Muhamed-Kheir Taha, Philippe Stoeckel & Bradford D. Gessner. (2013) Mobile Microbiological Laboratory Support for Evaluation of a Meningitis Epidemic in Northern Benin. PLoS ONE 8:7, pages e68401.
Crossref
Rolando Pajon, Andrew M. Fergus & Dan M. Granoff. (2013) Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa. PLoS ONE 8:6, pages e66536.
Crossref
Ouli Xie, Andrew J. Pollard, Judith E. Mueller & Gunnstein Norheim. (2013) Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine. Vaccine 31:27, pages 2852-2861.
Crossref
Caroline L. Trotter, Seydou Yaro, Berthe-Marie Njanpop-Lafourcade, Aly Drabo, Sita S. Kroman, Regina S. Idohou, Oumarou Sanou, Leah Bowen, Helen Findlow, Serge Diagbouga, Bradford D. Gessner, Ray Borrow & Judith E. Mueller. (2013) Seroprevalence of Bactericidal, Specific IgG Antibodies and Incidence of Meningitis Due to Group A Neisseria meningitidis by Age in Burkina Faso 2008. PLoS ONE 8:2, pages e55486.
Crossref
L. Agier, A. Deroubaix, N. Martiny, P. Yaka, A. Djibo & H. Broutin. (2013) Seasonality of meningitis in Africa and climate forcing: aerosols stand out. Journal of The Royal Society Interface 10:79, pages 20120814.
Crossref
Lydiane Agier, Hélène Broutin, Eric Bertherat, Mamoudou H. Djingarey, Clement Lingani, William Perea & Stéphane Hugonnet. (2013) Timely detection of bacterial meningitis epidemics at district level: a study in three countries of the African Meningitis Belt. Transactions of The Royal Society of Tropical Medicine and Hygiene 107:1, pages 30-36.
Crossref
. 2013. Bioconjugate Techniques. Bioconjugate Techniques 1017 1094 .
Haoua Tall, Stéphane Hugonnet, Philippe Donnen, Michèle Dramaix-Wilmet, Ludovic Kambou, Frank Drabo & Judith E Mueller. (2012) Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study. BMC Infectious Diseases 12:1.
Crossref
Ray Borrow. (2012) Advances with vaccination against Neisseria meningitidis . Tropical Medicine & International Health 17:12, pages 1478-1491.
Crossref
Alain Gervaix, Jean Taguebue, Béatrice Ninet Bescher, Jacques Corbeil, Frédéric Raymond, Gabriel Alcoba, Marie Kobela & Ekoe Tetanye. (2012) Bacterial Meningitis and Pneumococcal Serotype Distribution in Children in Cameroon. Pediatric Infectious Disease Journal 31:10, pages 1084-1087.
Crossref
Siddhivinayak Hirve, Ashish Bavdekar, Anand Pandit, Sanjay Juvekar, Malini Patil, Marie-Pierre Preziosi, Yuxiao Tang, Elisa Marchetti, Lionel Martellet, Helen Findlow, Cheryl Elie, Varsha Parulekar, Brian Plikaytis, Ray Borrow, George Carlone, Prasad S. Kulkarni, Akshay Goel, Karupothula Suresh, Suresh Beri, Subhash Kapre, Suresh Jadhav, Jean-Marie Preaud, Simonetta Viviani & F. Marc LaForce. (2012) Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2–10 years: A Phase II/III double-blind randomized controlled trial. Vaccine 30:45, pages 6456-6460.
Crossref
Helen Won, Samuel Yang, Charlotte Gaydos, Justin Hardick, Padmini Ramachandran, Yu-Hsiang Hsieh, Alexander Kecojevic, Berthe-Marie Njanpop-Lafourcade, Judith E. Mueller, Tsidi Agbeko Tameklo, Kossi Badziklou, Bradford D. Gessner & Richard E. Rothman. (2012) A broad range assay for rapid detection and etiologic characterization of bacterial meningitis: performance testing in samples from sub-Sahara. Diagnostic Microbiology and Infectious Disease 74:1, pages 22-27.
Crossref
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish. (2012) Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups . Clinical Investigation 2:2, pages 177-188.
Crossref
Caroline L. Trotter, Helen Findlow & Ray Borrow. (2012) Seroprevalence of Serum Bactericidal Antibodies against Group W135 and Y Meningococci in England in 2009. Clinical and Vaccine Immunology 19:2, pages 219-222.
Crossref
Judith E. Mueller, Seydou Yaro, Berthe-Marie Njanpop-Lafourcade, Aly Drabo, Régina S. Idohou, Sita S. Kroman, Oumarou Sanou, Serge Diagbouga, Yves Traoré, Lassana Sangaré, Raymond Borrow & Bradford D. Gessner. (2011) Study of a Localized Meningococcal Meningitis Epidemic in Burkina Faso: Incidence, Carriage, and Immunity. The Journal of Infectious Diseases 204:11, pages 1787-1795.
Crossref
Rolando Pajon, Andrew M. Fergus, Oliver Koeberling, Dominique A. Caugant & Dan M. Granoff. (2011) Meningococcal Factor H Binding Proteins in Epidemic Strains from Africa: Implications for Vaccine Development. PLoS Neglected Tropical Diseases 5:9, pages e1302.
Crossref
Judith E. Mueller & Bradford D. Gessner. (2010) A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt. International Journal of Infectious Diseases 14:7, pages e553-e559.
Crossref
F. Marc LaForce, Neil Ravenscroft, Mamoudou Djingarey & Simonetta Viviani. (2009) Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: A persistent problem with an imminent solution. Vaccine 27, pages B13-B19.
Crossref
Solenne Philippon, Hélène Broutin, Guillaume Constantin de Magny, Kandioura Toure, Cheick Hamala Diakite, Nicole Fourquet, Marie-Françoise Courel, Benjamin Sultan & Jean-François Guégan. (2009) Meningococcal meningitis in Mali: a long-term study of persistence and spread. International Journal of Infectious Diseases 13:1, pages 103-109.
Crossref
Masharip Atadzhanov. 2009. Manson's Tropical Diseases. Manson's Tropical Diseases 259 274 .
Dan M. Granoff, Lee H. Harrison & Ray Borrow. 2008. Vaccines. Vaccines 399 434 .
Marc Lipsitch & Justin J O'Hagan. (2007) Patterns of antigenic diversity and the mechanisms that maintain them. Journal of The Royal Society Interface 4:16, pages 787-802.
Crossref
Philippe De Wals, Laurent Coudeville, Pierre Trottier, Catherine Chevat, Lonny J. Erickson & Van Hung Nguyen. (2007) Vaccinating adolescents against meningococcal disease in Canada: A cost-effectiveness analysis. Vaccine 25:29, pages 5433-5440.
Crossref
Nahid Bhadelia, Mary Klotman & Daniel Caplivski. (2007) The HIV-Positive Traveler. The American Journal of Medicine 120:7, pages 574-580.
Crossref
Caroline L. Trotter & Mary E. Ramsay. (2007) Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. FEMS Microbiology Reviews 31:1, pages 101-107.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.